US Patent Issued to ETABLISSEMENT FRANCAIS DU SANG on May 19 for "Recombinant full-length single chain immunoglobulins" (French Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,634, issued on May 19, was assigned to ETABLISSEMENT FRANCAIS DU SANG (Saint Denis, France).

"Recombinant full-length single chain immunoglobulins" was invented by Yannic Danger (Saint Denis, France) and Michel Cogne (Saint Denis, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an antibody comprising an immunoglobulin heavy chain variable region (VH), an immunoglobulin light chain variable region (VL), an immunoglobulin light chain constant region (CL), an immunoglobulin heavy chain constant region (CH), and two sequences encoding peptide linkers (PL1 and PL2), wherein VH is fused to VL through PL1 and CL is fus...